Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, October 14, 2025
Codis, a newly established contract development and manufacturing organization (CDMO), has entered the pharmaceutical outsourcing market with a focus on commercial-scale spray drying and amorphous solid dispersion technologies.
read more
Monday, November 11, 2019
Goodwin Biotechnology has recently licensed an industry leading electronic content and document management solution to enhance the efficiency and effectiveness of its Quality systems and operations.
read more
Emergent BioSolutions will collaborate with Novavax to support bringing into the clinic Novavax’s novel experimental vaccine candidate to protect against coronavirus disease (COVID-19).
read more
Debiopharm has entered into a worldwide, exclusive license & research agreement with 3BP to further the development of their radioligand program which targets the CAIX enzyme.
read more
Rentschler Biopharma and Horizon Discovery announced the signing of a commercial license agreement.
read more
Thursday, January 14, 2016
Eurofins Scientific has announced the acquisition of Sinensis Life Sciences B.V. a provider of pharmaceutical product testing and cGMP Quality Control (QC) services in the Netherlands.
read more
Saturday, January 28, 2017
Porton Fine Chemicals, a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, has announced that Porton USA, L.L.C., a wholly-owned subsidiary of Porton, has entered into a stock purchase ...
read more
Mapi Pharma announced it will dedicate capacity at its manufacturing facility to support the global effort to provide COVID-19 vaccination to Israel, the EU and globally.
read more
Wednesday, April 10, 2019
Moleculin Biotech announced it has successfully expanded the clinical supply of Annamycin for its on-going clinical trials via BSP Pharmaceuticals S.p.A. in Latina, Italy.
read more
Friday, September 23, 2016
WuXi Biologics, an open-access R&D capability and technology platform company dedicated to biologics and a WuXi AppTec company, has announced the opening of a new commercial-scale cGMP biologics perfusion manufacturing facility in Wuxi city, China.
read more
Paratek Pharmaceuticals announced it has entered into a collaboration with Zai Lab, a biopharmaceutical company based in China, to support the development and commercialization of omadacycline for patients in China.
read more
Tuesday, December 19, 2017
ClearPath has initiated a third research collaboration with Astellas Pharma to combat infections.
read more
Grand River Aseptic Manufacturing has announced its second equipment purchase this year: a state-of-the-art Bausch+Ströbel fully integrated high-speed filling line with SKAN isolator.
read more
Wednesday, December 05, 2018
Icagen has entered into a license and collaboration agreement with Roche to develop and commercialize small molecule ion channel modulators for the treatment of neurological disorders.
read more
Pharm-Olam, a global midsized clinical research organization, has completed a change of ownership transaction on Friday June 19, 2020.
read more